Abstract
Twenty-four amateur climbers took part in a double-blind controlled cross-over trial of acetazolamide versus placebo for the prevention of acute mountain sickness. They climbed Kilimanjaro (5895 m) and Mt Kenya (5186 m) in three weeks with five rest days between ascents. The severity of acute mountain sickness was gauged by a score derived from symptoms recorded daily by each subject. On kilimanjaro those taking acetazolamide reached a higher altitude (11 v 4 reached the summit) and had a lower symptom score than those taking placebo (mean 4.8 v 14.3). Those who had taken acetazolamide on Kilimanjaro maintained their low symptom scores while taking placebo on Mt Kenya (mean score 1.9), whereas those who had taken placebo on Kilimanjaro experienced a pronounced improvement when they took acetazolamide on Mt Kenya (mean score 2.5). Acute mountain sickness prevented one subject for completing either ascent. Acetazolamide was acceptable to 23 of the 24 subjects. Acetazolamide is recommended as an acceptable and effective prophylactic for acute mountain sickness.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cain S. M., Dunn J. E., 2nd Low doses of acetazolamide to aid accommodation of men to altitude. J Appl Physiol. 1966 Jul;21(4):1195–1200. doi: 10.1152/jappl.1966.21.4.1195. [DOI] [PubMed] [Google Scholar]
- Evans W. O., Robinson S. M., Horstman D. H., Jackson R. E., Weiskopf R. B. Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide. Aviat Space Environ Med. 1976 May;47(5):512–516. [PubMed] [Google Scholar]
- Forwand S. A., Landowne M., Follansbee J. N., Hansen J. E. Effect of acetazolamide on acute mountain sickness. N Engl J Med. 1968 Oct 17;279(16):839–845. doi: 10.1056/NEJM196810172791601. [DOI] [PubMed] [Google Scholar]
- Gray G. W., Bryan A. C., Frayser R., Houston C. S., Rennie I. D. Control of acute mountain sickness. Aerosp Med. 1971 Jan;42(1):81–84. [PubMed] [Google Scholar]
- Hackett P. H., Rennie D., Levine H. D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976 Nov 27;2(7996):1149–1155. doi: 10.1016/s0140-6736(76)91677-9. [DOI] [PubMed] [Google Scholar]
- Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutton J. R., Houston C. S., Mansell A. L., McFadden M. D., Hackett P. M., Rigg J. R., Powles A. C. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med. 1979 Dec 13;301(24):1329–1331. doi: 10.1056/NEJM197912133012406. [DOI] [PubMed] [Google Scholar]